To investigate the relationship between TRAF3IP3 expression levels and the prognosis of HCC patients undergoing immunotherapy, we conducted an analysis on prognosis differences in high and low TRAF3IP3 expression groups among HCC patients receiving immunotherapy. Here, TRAF3IP3 is linked to hepatocellular carcinoma.